We identify PRDX1 expression levels as an independent marker of favorable outcome in ER-positive tumors and elucidate a unique role for PRDX1 in maintaining ERα expression in breast cancer cells subjected to oxidative stress. Here, PRDX1 is linked to breast carcinoma.